Senile Dementia and Glaucoma: Evidence for a Common Link
1Illinois Eye and Ear Infirmary, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago College of Medicine, Chicago, IL, USA.
Journal of Ophthalmic & Vision Research
|October 2, 2015
Summary
Dementia and glaucoma share neurodegenerative pathways, with shared biomarkers like tau and amyloid-beta. Further research into their links could reveal new treatments for both cognitive and visual dysfunction.
Area of Science:
- Neuroscience
- Ophthalmology
- Gerontology
Background:
- Dementia and glaucoma are neurodegenerative conditions causing cognitive and visual impairment, respectively.
- Both conditions increase in prevalence with age, but their co-occurrence suggests deeper links.
- Shared structural and molecular pathologies are observed in both diseases.
Purpose of the Study:
- To explore the potential pathophysiological links between dementia and glaucoma.
- To investigate shared mechanisms such as neurotoxin involvement and pressure gradients.
- To highlight the need for further research into the overlapping nature of these diseases.
Main Methods:
- Review of existing evidence on structural and molecular similarities between dementia and glaucoma.
- Analysis of potential pathophysiological mechanisms including neurotoxic substances (tau, amyloid-beta) and intracranial pressure.
- Examination of apoptosis pathways and cerebrospinal fluid dynamics in relation to optic nerve damage.
Main Results:
- Evidence suggests shared neurodegenerative processes involving abnormal tau and amyloid-beta.
- Low intracranial pressure may contribute to optic nerve damage via a high translaminar pressure gradient and altered CSF flow.
- These factors may potentiate neurotoxin accumulation along optic nerves, exacerbating damage.
Conclusions:
- Overlapping pathophysiology exists between dementia and glaucoma, necessitating further investigation.
- Understanding these links could lead to novel therapeutic strategies for both conditions.
- A lower threshold for glaucoma screening in dementia patients may be clinically prudent.
Related Concept Videos
Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Photoreceptors and Visual Pathways
11.1K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
11.1K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
810
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
810
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K


